Compare · CLX vs PROG
CLX vs PROG
Side-by-side comparison of Clorox Company (CLX) and Progenity Inc. (PROG): market cap, price performance, sector, and recent activity on the wire.
Summary
- CLX operates in Consumer Discretionary, while PROG operates in Consumer Durables - the two are in different parts of the market.
- CLX is the larger of the two at $11.71B, about 53.0x PROG ($221.1M).
- CLX has hit the wire 4 times in the past 4 weeks while PROG has been quiet.
- CLX has more recent analyst coverage (25 ratings vs 2 for PROG).
- Company
- Clorox Company
- Progenity Inc.
- Price
- $96.78-1.50%
- $0.86-5.14%
- Market cap
- $11.71B
- $221.1M
- 1M return
- +5.18%
- -
- 1Y return
- -21.82%
- -
- Industry
- Specialty Chemicals
- Specialty Chemicals
- Exchange
- NYSE
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 0
- Recent ratings
- 25
- 2
Clorox Company
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.
Progenity Inc.
Progenity, Inc., a biotechnology company, provides develops and commercializes molecular testing products in the United States. It offers Innatal, a noninvasive prenatal screening test offered to women early in pregnancy to screen for chromosome abnormalities, such as down syndrome, trisomy 18, trisomy 13, and sex chromosome disorders through the analysis of cell-free DNA; Preparent that screens for carrier status of hereditary diseases prior to or early in pregnancy; and Riscover, a hereditary cancer screen that analyzes 31 genes associated with inherited risk of 12 types of cancers, including the BRCA1/2 genes for hereditary breast, ovarian, colorectal, endometrial, pancreatic, and other cancer syndromes, as well as for the five genes associated with Lynch syndrome. The company also provides Resura, a noninvasive prenatal test for families at risk for rare single gene disorders; and Preecludia, a preeclampsia rule-out test. In addition, it offers anatomic and molecular pathology tests, and COVID-19 PCR testing services, as well as test products that includes chromosomal microarray for pregnancy loss, which evaluates the genetic cause of miscarriage; maternal serum screening for chromosomal disorders; and preimplantation genetic testing for use with artificial reproductive technologies. Further, the company develops therapeutic solutions for gastrointestinal-related disorders, such as PGN-001, PGN-300, PGN-600, and PGN-OB2. It also owns and operates laboratory. Progenity, Inc. was formerly known as Ascendant MDX, Inc. and changed its name to Progenity, Inc. in November 2013. The company was founded in 2010 and is headquartered in San Diego, California.
Latest CLX
- Clorox Healthcare Introduces Two Breakthrough Innovations to Help Solve Infection Prevention Challenges
- SEC Form SD filed by Clorox Company
- Clorox Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits
- Clorox Board of Directors to Initiate Comprehensive CEO Search Process
- Clorox to Present at dbAccess Global Consumer Conference
- Clorox Company filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Hidden Valley™ Ranch Expands into Protein-Forward Snacking with New Line of Seasoned Chicken Dippers
- SEC Form FWP filed by Clorox Company
- SEC Form 424B3 filed by Clorox Company
- Director Breber Pierre R bought $429,124 worth of shares (5,000 units at $85.82) (SEC Form 4)
Latest PROG
- Progenity Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- SEC Form SC 13D/A filed by Progenity Inc. (Amendment)
- Progenity Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Progenity Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
- SEC Form 4: Athyrium Opportunities Iii Co-Invest 1 Lp returned 42,362 units of Series X Preferred Stock to the company
- SEC Form 4: Kotzin Brian L. returned 44 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Mohanty Aditya P. returned 178 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Alter Jeffrey D. returned 65 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Neumann Clarke returned 44 units of Series X Preferred Stock to the company, closing all direct ownership in the company
- SEC Form 4: Powell Lynne returned 45 units of Series X Preferred Stock to the company, closing all direct ownership in the company